• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT MEDICAL NAVITOR; AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIVERED

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT MEDICAL NAVITOR; AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIVERED Back to Search Results
Catalog Number NVTR-27
Device Problem Difficult to Fold, Unfold or Collapse (1254)
Patient Problems Obstruction/Occlusion (2422); Insufficient Information (4580)
Event Date 08/29/2022
Event Type  Injury  
Manufacturer Narrative
Investigation is not yet complete.A follow-up report will be submitted with all additional relevant information.
 
Event Description
It was reported that on (b)(6) 2022, a 27mm navitor valve was chosen for a transcatheter aortic valve replacement using a flexnav delivery system via subclavian access route.During procedure, the intima of the right subclavian artery was dissected by the nose cone and capsule of the delivery system, which occluded the subclavian artery.After advancing a guidewire from the right radial artery and another guidewire from the right femoral artery to cross the lesioned area, the femoral artery guidewire was pulled through using the snare from the radial artery guidewire.A balloon valvuloplasty pre-dilatation was performed with a non-abbott balloon, diameter of 6mm by length of 40mm.A non-abbott stent, diameter of 7mm by length of 40mm, was implanted.The navitor valve was implanted.A balloon valvuloplasty post-dilatation was performed with a non-abbott balloon, diameter of 6mm by length of 40mm.The dissection was also on the central side of the right common carotid artery, but no additional treatment was performed because of the possibility of occlusion or stenosis of the right common carotid artery.
 
Manufacturer Narrative
An event of external native interference affecting the expansion of the valve was reported.A returned device assessment could not be performed as the device remains implanted and was not returned for analysis.The device history record was reviewed to ensure that each manufacturing and inspection operation was performed including the valve meeting stent radial force specifications, and the product met all specifications.Based on the information received, the cause of the reported incident could not be conclusively determined.H6 health effect - clinical code: code 4580 removed.
 
Event Description
It was reported that on (b)(6) 2022, a 27mm navitor valve was chosen for a transcatheter aortic valve replacement using a flexnav delivery system via subclavian access route.During procedure, the intima of the right subclavian artery was dissected by the nose cone and capsule of the delivery system, which occluded the subclavian artery.After advancing a guidewire from the right radial artery and another guidewire from the right femoral artery to cross the lesioned area, the femoral artery guidewire was pulled through using the snare from the radial artery guidewire.A balloon valvuloplasty pre-dilatation was performed with a non-abbott balloon, diameter of 6mm by length of 40mm.A non-abbott stent, diameter of 7mm by length of 40mm, was implanted.The navitor valve was implanted.A balloon valvuloplasty post-dilatation was performed with a non-abbott balloon, diameter of 6mm by length of 40mm.The dissection was also on the central side of the right common carotid artery, but no additional treatment was performed because of the possibility of occlusion or stenosis of the right common carotid artery.Subsequent to the previously filed report, additional information was received that the aortic annulus diameter was 24.2mm.The final implant depth of the valve was in the appropriate position.The right subclavian access route was utilized due to a shaggy aorta, and there was a risk of plaque in both of the patient's inguinal regions.The patient's left subclavian artery had a high risk of vascular complications due to calcification and a narrow lumen, which was why the right subclavian access route was utilized.The micro adjustment wheel was used during loading of the device to close the gap between the valve capsule and the radiopaque tip, and the distal end was exterior and straightened when the micro adjustment wheel was used.Before insertion into the blood vessel, a gap was intentionally created in advance with the nosecone in order to prevent over-capture when inserting the delivery system into the blood vessel.There was strong resistance when the delivery catheter was inserted into the access blood vessel.The intima of the right subclavian artery was dissected by the nose cone and capsule of the delivery system during the insertion of the delivery catheter.It was thought that the dissection did not occur due to the gap between the nose cone and the capsule, but because the capsule exceeded the distal edge of the nosecone, known as over-capture.Once the delivery system was removed from the body, the over-capture was observed.There was sufficient calcium present to allow sealing, but the annular calcium distribution was unknown.There was an external native interference affecting the expansion of the valve, which was why a post-dilatation balloon valvuloplasty was performed after valve deployment.The patient status was unknown.The patient did not have a history of pulmonary hypertension.The patient did not require a blood transfusion.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
NAVITOR
Type of Device
AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIVERED
Manufacturer (Section D)
ABBOTT MEDICAL
5050 nathan lane n
plymouth MN 55442
Manufacturer (Section G)
ST. JUDE MEDICAL #3014918977
edificio #44 calle 0, ave. 2
el coyol alajuela 1897- 4050
CS   1897-4050
Manufacturer Contact
karen krouse
5050 nathan lane n
plymouth, MN 55442
6517565400
MDR Report Key15463222
MDR Text Key300370213
Report Number2135147-2022-01293
Device Sequence Number1
Product Code NPT
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
P190023
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 11/29/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/22/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue NumberNVTR-27
Device Lot Number8465366
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received11/29/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured04/19/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
FLEXNAV DELIVERY SYSTEM, FNAV-DS-LG, (B)(6); NAVITOR VALVE, NVTR-27, (B)(6)
Patient Outcome(s) Required Intervention;
Patient Age84 YR
Patient SexFemale
-
-